CEDRUS’s Amgen AMGN Stock Holding History

CEDRUS’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$291K	Sell	903 -42	-4%	-$13.7K	0.11%	145
2024 Q2	$295K	Buy	945 +131	+16%	+$38.5K	0.15%	124
2024 Q1	$231K	Buy	814 +72	+10%	+$21.1K	0.13%	137
2023 Q4	$214K	Buy	+742	New	+$202K	0.13%	139

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

CEDRUS's AMGN Position: Q3 2024 in Review

CEDRUS reduced its Amgen (AMGN) stake by 4.4% in Q3 2024, selling an estimated $13.7K and leaving 903 shares worth $291K. The position accounts for 0.11% of the portfolio, ranked #145.

CEDRUS first reported a position in AMGN in Q4 2023 and has held it in 4 quarters since. The position peaked at $295K in Q2 2024. 2,824 funds tracked by Wall St. Rank hold AMGN as of Q3 2024.

CEDRUS held 903 shares of Amgen worth $291K as of Q3 2024.
CEDRUS sold 42 Amgen shares in Q3 2024, an estimated $13.7K.
Amgen made up 0.11% of CEDRUS's portfolio in Q3 2024, its #145 holding.
CEDRUS first reported a position in Amgen in Q4 2023 and has held it in 4 quarters since.
CEDRUS's Amgen position peaked at $295K in Q2 2024.
2,824 funds tracked by Wall St. Rank held Amgen as of Q3 2024.

Based on CEDRUS's 13F filing for Q3 2024, filed 18 Oct 2024.